The BRAF-mutated pathway consists of valine replacement with glutamic acid in the BRAF gene at location 600 of the polypeptide chain, transforming it in an active kinase, which is responsible for tumour resistance due to reactivation of the mitogen-activated protein kinase (MAPK) pathway [59]. The gene discussed is BRAF; the disease is neoplasm.